Li Q, Xia C, Li H et al (2024) Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics. Front Med 18(5):911–920. https://doi.org/10.1007/s11684-024-1058-6

Article  PubMed  CAS  Google Scholar 

Kennedy A, Cohn M, Coldwell DM et al (2018) Erratum to updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases. J Gastrointest Oncol 9(2):E13–E14. https://doi.org/10.21037/jgo.2018.03.12

Article  PubMed  PubMed Central  Google Scholar 

National Health Commission of the People′s Republic of China; Chinese Society of Oncology (2023) Chinese Protocol of Diagnosis and Treatment of Colorectal Cancer (2023 edition). Zhonghua Wai Ke Za Zhi 61(8):617–644. https://doi.org/10.3760/cma.j.cn112139-20230603-00222

Article  Google Scholar 

Benson AB, Venook AP, Al-Hawary MM et al (2022) Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 20(10):1139–1167. https://doi.org/10.6004/jnccn.2022.0051

Article  PubMed  CAS  Google Scholar 

Gérard JP, Conroy T, Bonnetain F et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol 24(28):4620–4625. https://doi.org/10.1200/JCO.2006.06.7629

Article  PubMed  Google Scholar 

Conroy T, Castan F, Etienne PL et al (2024) Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol 35(10):873–881. https://doi.org/10.1016/j.annonc.2024.06.019

Article  PubMed  CAS  Google Scholar 

Maas M, Nelemans PJ, Valentini V et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11(9):835–844. https://doi.org/10.1016/S1470-2045(10)70172-8

Article  PubMed  Google Scholar 

Agarwal A, Chang GJ, Hu CY et al (2013) Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer 119(24):4231–4241. https://doi.org/10.1002/cncr.28331

Article  PubMed  Google Scholar 

McCoy MJ, Hemmings C, Anyaegbu CC et al (2017) Tumour-infiltrating regulatory t cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response. Oncotarget 8(12):19803–19813. https://doi.org/10.18632/oncotarget.15048

Article  PubMed  PubMed Central  Google Scholar 

Yi Y, Shen L, Shi W et al (2021) Gut microbiome components predict response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a prospective, longitudinal study. Clin Cancer Res 27(5):1329–1340. https://doi.org/10.1158/1078-0432.CCR-20-3445

Article  PubMed  CAS  Google Scholar 

Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247. https://doi.org/10.1016/j.ejca.2008.10.026

Article  PubMed  CAS  Google Scholar 

Park IJ, You YN, Agarwal A et al (2012) Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol 30(15):1770–1776. https://doi.org/10.1200/JCO.2011.39.7901

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zeng WG, Liang JW, Wang Z et al (2015) Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. Chin J Cancer 34(10):468–474. https://doi.org/10.1186/s40880-015-0033-7

Article  PubMed  CAS  Google Scholar 

Bugg WG, Andreou AK, Biswas D, Toms AP, Williams SM (2014) The prognostic significance of MRI-detected extramural venous invasion in rectal carcinoma. Clin Radiol 69(6):619–623. https://doi.org/10.1016/j.crad.2014.01.010

Article  PubMed  CAS  Google Scholar 

McCawley N, Clancy C, O’Neill BD, Deasy J, McNamara DA, Burke JP (2016) Mucinous rectal adenocarcinoma is associated with a poor response to neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Dis Colon Rectum 59(12):1200–1208. https://doi.org/10.1097/DCR.0000000000000635

Article  PubMed  Google Scholar 

Song M, Li S, Wang H et al (2022) MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicts response to neoadjuvant therapy in rectal cancer. Br J Cancer 127(2):249–257. https://doi.org/10.1038/s41416-022-01786-7

Article  PubMed  PubMed Central  CAS  Google Scholar 

Feng L, Liu Z, Li C et al (2022) Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digit Health 4(1):e8–e17. https://doi.org/10.1016/S2589-7500(21)00215-6

Article  PubMed  CAS  Google Scholar 

Bedrikovetski S, Traeger L, Vather R, Moore JW, Sammour T (2023) Clinical and biochemical predictors of tumor response after neoadjuvant therapy in rectal cancer. Asia Pac J Clin Oncol 19(3):365–373. https://doi.org/10.1111/ajco.13877

Article  PubMed  Google Scholar 

Gambacorta MA, Masciocchi C, Chiloiro G et al (2021) Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials. Radiother Oncol 154:154–160. https://doi.org/10.1016/j.radonc.2020.09.026

Article  PubMed  CAS  Google Scholar 

Huang W, Wang S, Zhang H, Zhang B, Wang C (2018) Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer. Cancer Biol Med 15(1):88–96. https://doi.org/10.20892/j.issn.2095-3941.2017.0124

Article  PubMed  PubMed Central  CAS  Google Scholar 

Beer JH, Haeberli A, Vogt A et al (2002) Coagulation markers predict survival in cancer patients. Thromb Haemost 88(5):745–749

PubMed  CAS  Google Scholar 

Shibutani M, Kashiwagi S, Fukuoka T, Iseki Y, Kasashima H, Maeda K (2023) The significance of the D-dimer level as a prognostic marker for survival and treatment outcomes in patients with stage IV colorectal cancer. In Vivo 37(1):440–444. https://doi.org/10.21873/invivo.13097

Article  PubMed  PubMed Central  CAS  Google Scholar 

Muscaritoli M, Arends J, Bachmann P et al (2021) Espen practical guideline: clinical nutrition in cancer. Clin Nutr 40(5):2898–2913. https://doi.org/10.1016/j.clnu.2021.02.005

Article  PubMed  Google Scholar 

Xie H, Wei L, Yuan G, Liu M, Tang S, Gan J (2022) Prognostic value of prognostic nutritional index in patients with colorectal cancer undergoing surgical treatment. Front Nutr 9:794489. https://doi.org/10.3389/fnut.2022.794489

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hu H, Kang L, Zhang J et al (2022) Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial. Lancet Gastroenterol Hepatol 7(1):38–48. https://doi.org/10.1016/S2468-1253(21)00348-4

Article  PubMed  CAS  Google Scholar 

Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–1740. https://doi.org/10.1056/NEJMoa040694

Article  PubMed  CAS  Google Scholar 

Momma T, Okayama H, Kanke Y et al (2021) Validation of gene expression-based predictive biomarkers for response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Cancers (Basel) 13(18):4642. https://doi.org/10.3390/cancers13184642

Article  PubMed  CAS  Google Scholar 

Garcia-Aguilar J, Chow OS, Smith DD et al (2015) Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol 16(8):957–966. https://doi.org/10.1016/S1470-204